377 related articles for article (PubMed ID: 35093242)
1. Is Omicron the last SARS-CoV-2 Variant of Concern?
Rahimi F; Talebi Bezmin Abadi A
Arch Med Res; 2022 Apr; 53(3):336-338. PubMed ID: 35093242
[TBL] [Abstract][Full Text] [Related]
2. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
[TBL] [Abstract][Full Text] [Related]
3. Has Omicron Changed the Evolution of the Pandemic?
Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
[TBL] [Abstract][Full Text] [Related]
4. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
[TBL] [Abstract][Full Text] [Related]
5. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
[TBL] [Abstract][Full Text] [Related]
6. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.
Dhama K; Nainu F; Frediansyah A; Yatoo MI; Mohapatra RK; Chakraborty S; Zhou H; Islam MR; Mamada SS; Kusuma HI; Rabaan AA; Alhumaid S; Mutair AA; Iqhrammullah M; Al-Tawfiq JA; Mohaini MA; Alsalman AJ; Tuli HS; Chakraborty C; Harapan H
J Infect Public Health; 2023 Jan; 16(1):4-14. PubMed ID: 36446204
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
Wang L; Cheng G
J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
[TBL] [Abstract][Full Text] [Related]
8. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Omicron variant: Why global communities should take it seriously?
Rahmani S; Rezaei N
Immun Inflamm Dis; 2022 May; 10(5):e618. PubMed ID: 35478443
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
CDC COVID-19 Response Team
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
[TBL] [Abstract][Full Text] [Related]
11. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
12. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
[TBL] [Abstract][Full Text] [Related]
13. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City.
Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE
J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
15. The Deltacron conundrum: Its origin and potential health risks.
Farheen S; Araf Y; Tang YD; Zheng C
J Med Virol; 2022 Nov; 94(11):5096-5102. PubMed ID: 35815524
[TBL] [Abstract][Full Text] [Related]
16. An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.
Rathinasamy M; Kandhasamy S
J Med Virol; 2022 Jun; 94(6):2414-2421. PubMed ID: 35112734
[TBL] [Abstract][Full Text] [Related]
17. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into SARS-CoV-2 omicron variant.
Silva SJRD; Kohl A; Pena L; Pardee K
Rev Med Virol; 2023 Jan; 33(1):e2373. PubMed ID: 35662313
[TBL] [Abstract][Full Text] [Related]
19. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
Kannan S; Shaik Syed Ali P; Sheeza A
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
[TBL] [Abstract][Full Text] [Related]
20. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic.
Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD
Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
